Document is current

Article History

Received: 15 June 2022

Accepted: 2 October 2023

First Online: 19 October 2023

Declarations

:

: The use of tissue specimens collected at Semmelweis University in this study was approved by the Hungarian Scientific Research Ethics Committee (ETT TUKEB IV/3961–2/2020/EKU). Samples and data were managed anonymously. At the University Hospital Zurich, small quantities of bodily substances removed in the course of an autopsy were anonymized for research purposes without consent, in the absence of a documented refusal of the deceased persons. In accordance with the Swiss Federal Act on Research involving Human Beings, this study did not require institutional board approval. Subsequent experiments were approved by the Swedish Ethical Review Authority (2010/313–31/3, 2018/689–32).

: Not applicable.

: H.S., Y.M., and S.G. are scientific advisors to 10X Genomics, Inc. which holds IP rights to the ST technology and previously acquired ReadCoor and Cartana and their accompanying intellectual property rights. S.G. holds 10X Genomics stocks. H.S., Y.M., E.B., A.H., and S.G. are co-inventors of patent filings relating to this work. E.B., A.H., A.J., and A.N. are employees of 10X Genomics and hold stock options. All other authors declare no competing interests.